Maze Therapeutics, Inc. (MAZE) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -39.11M | -27.73M | -24.64M | -30.05M | -29.52M | -22.45M | -23.2M | 145.05M | -20.64M |
| Operating CF Margin % | -195.56% | - | - | - | - | - | -928.2% | 87.91% | - |
| Operating CF Growth % | -32.51% | -23.51% | -6.19% | -120.72% | - | -8.76% | - | - | - |
| Net Income | -24.21M | -34.57M | -30.09M | -33.68M | -32.79M | -29.58M | -24.75M | 139.06M | -26.58M |
| Depreciation & Amortization | 444K | 499K | 571K | 649K | 684K | 705K | 788K | 854K | 976K |
| Stock-Based Compensation | 0 | 6.07M | 3.86M | 3.24M | 3.23M | 2.85M | 2.34M | 2.14M | 2.56M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 8.33M | 577K | -1.45M | 779K | 785K | 2.54M | 3.65M | 567K | 4.65M |
| Working Capital Changes | -23.68M | -311K | 2.46M | -1.04M | -1.43M | 1.03M | -5.23M | 2.43M | -2.25M |
| Change in Receivables | -20M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 2.21M | -1.13M | -748K | 1.27M | 579K | 821K | -1.17M | 387K | -25K |
| Cash from Investing | 6.28M | -103.39M | -66.88M | -393K | -299K | -605K | -103K | -160K | -34K |
| Capital Expenditures | -93K | -34K | -68K | -393K | -299K | -605K | -103K | -160K | -34K |
| CapEx % of Revenue | 0.46% | - | - | - | - | - | 4.12% | 0.1% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 42.36M | 3.59M | 143.76M | 612K | 127.38M | 70.26M | -2.15M | 154K | 16.19M |
| Debt Issued (Net) | 38.52M | 0 | 0 | 0 | 0 | -16.18M | 0 | 259K | 16.18M |
| Equity Issued (Net) | 3.84M | 3.59M | -128.36M | 612K | 127.75M | 70.26M | 0 | 0 | 12K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 272.12M | 0 | -374K | 16.18M | -2.15M | -105K | 0 |
| Net Change in Cash | 9.52M | -127.53M | 52.23M | -29.83M | 97.56M | 47.2M | -25.46M | 145.04M | -4.49M |
| Free Cash Flow | -39.21M | -27.76M | -24.71M | -30.45M | -29.82M | -23.06M | -23.31M | 144.89M | -20.68M |
| FCF Margin % | -196.03% | - | - | - | - | - | -932.32% | 87.81% | - |
| FCF Growth % | -31.5% | -20.41% | -6.02% | -121.01% | - | -11.51% | - | - | - |
| FCF per Share | -0.73 | -0.65 | -0.54 | -0.69 | -0.68 | -0.53 | -0.53 | 3.31 | -0.47 |
| FCF Conversion (FCF/Net Income) | 1.62x | 0.80x | 0.82x | 0.89x | 0.90x | 0.76x | 0.94x | 1.04x | 0.78x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |